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meferral for epicardial ablation frequently represents a “last
itch” effort in uniquely difficult patients. Epicardial map-
ing was the cornerstone that guided our early experience in
he surgical ablation of arrhythmias (1). However, epicardial
apping alone was insufficient to identify the site of origin of
entricular tachycardias (VTs), particularly in patients with
oronary artery disease and myocardial infarctions (2,3).
See page 2366
In contrast to the surgical approach, catheter ablation has
volved from the endocardium to the epicardium. Despite
he advent of electroanatomical mapping systems, irrigated
atheters, and substrate mapping strategies, the long-term
fficacy of endocardial ablation is only modest (4,5). Failure
f endocardial ablation could reflect the presence of an
picardial or intramyocardial arrhythmia focus and the
naccessibility from the endovascular approach.
picardial Substrate for Ventricular Arrhythmia
he importance of epicardial VT circuits was first high-
ighted in Chagas’ disease, which classically results in an
picardial involvement in approximately 70% of patients (6).
he technique of percutaneous access to the pericardial
pace was initially described by Sosa et al. (7). Case reports
ave shown that epicardial instrumentation in the electro-
hysiology laboratory is feasible and provides an alternative
reatment strategy in selected patients.
Nonendocardial substrates in scar-related as well as in
diopathic VTs have recently been increasingly recognized
6,8–13). In patients with left ventricular nonischemic
ardiomyopathy, endocardial VT ablation is associated with
lower success rate compared with patients with ischemic
eart disease (10,14,15). The initial attempt to characterize
he electrophysiological substrate in nonischemic cardiomy-
Editorials published in the Journal of the American College of Cardiology reflect the
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merican College of Cardiology.
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peakers’ Bureau of Biosense Webster.pathy demonstrated only modest-sized endocardial elec-
rographic abnormalities (15). Detailed epicardial mapping
as identified larger confluent low-voltage areas compared
ith the endocardial surface, often located over the basal
ateral left ventricle near the valve annulus (9,10,12). The
ow-amplitude electrograms recorded in these areas are
ypically wide, split, and/or late, which help distinguish scar
rom epicardial fat (12). In contrast to those with nonisch-
mic cardiomyopathy, patients with ischemic heart disease
end to have larger endocardial than epicardial scar, usually
onfined to a specific coronary vascular territory. Although
here is a predilection for a subendocardial location of the VT
ubstrate, the prevalence of epicardial circuits may be high,
articularly in patients with old inferior infarctions (16).
In patients with arrhythmogenic right ventricular cardio-
yopathy/dysplasia, sizable low-voltage areas often involve
he infundibulum, free wall, and basal perivalvular regions,
onstituting the endocardial substrate (17). However, de-
pite short-term success with endocardial catheter ablation,
ecurrences become increasingly common during long-term
ollow-up (18). More recently, the presence of extensive
picardial low-voltage areas, often with fractionated and late
lectrographic recordings, have been identified. The epicar-
ial scar is consistently larger than that on the endocardial
urface. The epicardial foci targeted for successful catheter
blation are also frequently located beyond the endocardial
efined scar (13).
Catheter ablation has been shown to be an effective
herapy for patients with idiopathic ventricular arrhythmia.
owever, occasional patients have been reported in whom
uch arrhythmia could not be ablated from the ventricular
ndocardium or from the aortic cusps. Often under-
ecognized, the incidence of an epicardial origin in idio-
athic VT may be as high as 9% (11). The mechanism of
hese catecholamine-sensitive arrhythmias is consistent with
riggered activity, commonly arising from areas adjacent to
picardial coronary vasculature (8,11).
his Study
espite the increasing recognition that ventricular arrhyth-
ias may originate from epicardial foci, epicardial VTblation remains a specialized procedure and is performed at
f
r
a
c
v
t
m
c
p
m
e
t
t
w
(
o
w
r
o
t
a
p
v
c
c
p
i
w
i
e
H
o
c
c
i
8
w
h
p
t
s
t
h
w
c
m
d
p
a
m
2
a
v
w
e
f
p
r
t
C
n
e
a
o
a
t
C
p
e
g
r
s
a
i
A
A
t
e
a
s
e
a
t
a
e
v
t
o
c
e
s
p
T
p
i
r
i
t
v
R
C
v
2374 Hsia JACC Vol. 55, No. 21, 2010
Epicardial VT Ablation May 25, 2010:2373–5ew centers. In this issue of the Journal, Sacher et al. (19)
eport their experiences with epicardial VT mapping and
blation, focusing on safety and complications. The study
ohort consisted of a referral patient population with a
ariety of diagnoses who underwent VT ablation at 3
ertiary centers between 2001 and 2007. This retrospective,
ulticenter analysis is the largest study to date on epicardial
atheter mapping and ablation. Of 913 VT ablations, 156
rocedures (17%) in 134 patients involved epicardial instru-
entation. The majority of the patients (86%) had prior
ndocardial ablation attempts. Epicardial access was ob-
ained in 136 procedures (about 90%) via subxiphoid punc-
ures. Failures of such a percutaneous approach (n  15)
ere mostly associated with histories of prior cardiac surgery
n 11) or pericarditis. Surgical subxiphoid window (20) or
pen-heart thoracotomy was used in the remaining patients.
A total of 14 procedure-related major complications (9%)
ere observed acutely or before discharge. Complications
elated to the epicardial approach (5%) included 7 episodes
f epicardial bleeding as well as 1 coronary stenosis, despite
he use of cryoablation in the vicinity of the right coronary
rtery. It is important to note that almost one-half of the
rocedure-related complications were related to the “con-
entional” endocardial approach. There were 3 delayed
omplications (2%) related to pericardial access. These
onsisted of a pericardial inflammatory reaction, late tam-
onade, and a late coronary occlusion with myocardial
nfarction. Constrictive pericarditis or phrenic nerve injuries
ere not observed in this study.
Epicardial access was successfully obtained in the major-
ty of the patients via a percutaneous subxiphoid approach,
ven in those who required repeated epicardial procedures.
owever, up to a 20% right ventricular perforation rate was
bserved, and major pericardial bleeding was the most
ommon complication (4.5%). Care must be taken to ensure
orrect guidewire position in the pericardial space before the
nsertion of a sheath. Patient selection is also important, as
5% of the failures of percutaneous subxiphoid punctures
ere in patients with previous cardiac surgery. In addition,
igh-output pacing and coronary angiography should be
erformed to define the course of the phrenic nerve (21) and
o confirm the absence of coronary arteries near the ablation
ite (22,23).
In addition to the safety data, Sacher et al. (19) also report
he percent of epicardial VTs in the global population. The
ighest prevalence of epicardial VT was observed in patients
ith the diagnoses of arrhythmogenic right ventricular
ardiomyopathy/dysplasia (41%) and nonischemic cardio-
yopathy (35%), followed by patients with ischemic heart
isease (16%). Overall, these findings are consistent with
rior observations. Soejima et al. (9) found epicardial
blation necessary in 28% of patients with dilated cardio-
yopathies, and Sosa et al. (16) found epicardial VTs in
3% of patients with VT late after myocardial infarction. It
ppears that epicardial involvement may be present to
arious degrees in a significant minority of patients with VT
5ith different cardiomyopathies, especially in whom prior
ndocardial approach has failed.
After a mean follow-up period of 23  21 months,
reedom from VT recurrence was observed in 71% of the
atients. This result is also similar to other published
eports, with rates of arrhythmia control ranging from 63%
o 78% among different patient populations (8,9,12,13).
onsidering that these studies included patients with sig-
ificant structural heart disease, the long-term efficacy of the
picardial VT ablation strategy appears quite respectable.
However, the endocardium was ultimately thought to be
better target than the epicardium in a significant minority
f the patients (up to 21%), and ablation was not performed
fter obtaining epicardial access. This highlights the impor-
ance of pre-operative evaluations and procedure planning.
areful analysis of the electrocardiogram during VT or
remature ventricular contraction is essential. Different
lectrocardiographic criteria for recognizing epicardial ori-
in of arrhythmia have been proposed (11,24,25). Magnetic
esonance imaging may also help identify epicardial sub-
trate in cardiomyopathies (26,27). Thorough pre-procedural
ssessment can facilitate an efficient mapping strategy and
mprove ablation outcomes.
n Evolution of Needs
nalogous to the evolution of transseptal catheterization,
he technique was well established but was embraced by
lectrophysiologists only after recognizing its potential in
rrhythmia interventions. The importance of epicardial
ubstrate for VT has only now been appreciated, and the
fficacy of epicardial VT ablation is encouraging, with an
cceptable complication rate. It is important to note that
hese findings reflect practices at centers that specialize in
rrhythmia management and may not be applicable to less
xperienced operators or centers. With up to a 20% risk for
entricular perforation, careful patient selection is impor-
ant, and the procedure should be performed by experienced
perators with surgical backup.
Reference criteria for electrographic recordings have re-
ently been established to allow better characterization of
lectroanatomical substrate on the epicardium (12). Future
tudies are needed to define the role of epicardial ablation as
atient populations and technologies continue to evolve.
he development of dedicated equipment for percutaneous
ericardial access as well as epicardial mapping and ablation
s also necessary. Other advances in technologies and
efinement in ablation techniques might allow us to better
mage the ventricular substrate, track online lesion forma-
ion, and minimize the risk for phrenic nerve or coronary
asculature damage.
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